Changes in antibiotic residues and the gut microbiota during ciprofloxacin administration throughout Silkie chicken development

Effects of chitooligosaccharide on the in vitro antibacterial activity against avian Escherichia coli and the pharmacokinetics of florfenicol in healthy chickens

This study investigates the combined effects of chitooligosaccharide (COS) and florfenicol (FLO) on the inhibition of Escherichia coli in vitro, as well as the pharmacokinetic interactions between these compounds in healthy chickens. The minimum inhibitory concentration (MIC) of COS and FLO alone and the fractional inhibitory concentration index (FICI) after combined treatment were determined using the broth microdilution method and checkerboard method, respectively. Additionally, we evaluated the pharmacokinetic interactions between the 2 types of COS and FLO in healthy chickens. Thirty chickens were randomly divided into 3 groups: Florfenicol group (30 mg/kg), COS J85 group (COS J85 20 mg/kg + florfenicol 30 mg/kg), COS H85 group (COS H85 20 mg/kg + florfenicol 30 mg/kg). Either FLO or COS was orally administered by gavage. The concentrations of FLO in chicken plasma were measured at different time points after the drug withdrawal using high-performance liquid chromatography (HPLC), and pharmacokinetic parameters were calculated by a compartmental method. The results showed that COS J85 and COS H85, when combined with FLO, had FICI values of 0.1875 to 0.75 and 0.3125 to 1, respectively, indicating good synergistic or additive effects against Escherichia coli. The pharmacokinetics of FLO alone and in combination with COS followed a 1-compartment model with first-order absorption and elimination. Furthermore, the pharmacokinetic analysis revealed that the elimination half-life (t1/2ke) of florfenicol was significantly increased in the COS H85 group compared to oral administration of florfenicol alone (P < 0.05). Other pharmacokinetic parameters did not show significant changes (P > 0.05), except between the 2 combined treatment groups, where statistical differences were observed for various parameters, excluding the area under the concentration-time curve from the time of dosing to infinity (AUC) and peak concentration (Cmax).

Protective effects of maternal administration of total saponins of Codonopsis pilosula in the mice offspring following diarrhea: role of immune function, antioxidant function, and intestinal inflammatory injury

Total saponins of Codonopsis (TSC) are a kind of critical bioactive substances in Codonopsis, which have anti-inflammatory, antioxidant, anti-ulcer, immunomodulatory effects, and protective effects on ulcerative enteritis. In this study, TSC (3.75 mL/kg, gavage) was administered once a day to 13-day gestation Kunming mice for 5 days. On day 13 of birth, the offspring were given Escherichia coli solution (0.15 mL/mouse, intraperitoneal injection) and senna leaf decoction (0.15 mL/mouse, gavage) once a day for 6 days. The results showed that gestation maternal administration of TSC effectively reduced the diarrhea index, increased the content of sIgA, IgG, SOD, and GSH, inhibited the TLR4/MyD88/NF-κB pathway in the intestine, reduced the expression of inflammatory factors, and alleviated intestinal injury in the littermates. The results provided a critical reference for the clinical application of TSC to control diarrhea in animal offspring.

A hybrid nanocomposite based on CuFe layered double hydroxide coated graphene oxide for photocatalytic degradation of trimethoprim

Photocatalytic activation of persulfate (PS) has recently been considered an effective and environmentally friendly approach for antibiotic decomposition due to its high treatment efficiency, low energy consumption, and high reliability. The development of safe and high-performance catalysts is important for PS-based advanced oxidation processes. In this study, a CuFe-layered double hydroxide (LDH) coated graphene oxide (CuFe-LDH/GO) composite was constructed as a photocatalyst for trimethoprim (TMP) decomposition. The CuFe-LDH/GO catalyst was prepared via the co-precipitation method and characterized through Fourier-transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), high-resolution transmission electron microscopy (HR-TEM), and X-ray electron microscopy (XPS) techniques. Characterization results revealed that GO was entirely covered by LDH platelets which also kept its hydrotalcite structure in the as-prepared nanocomposite. The average crystallite size of CuFe-LDH/GO was 28.22 nm. The results confirmed that CuFe-LDH/GO exhibited excellent performance for the PS activation with a TMP removal efficiency of 90.8% under UV-light irradiation. Compared with pristine CuFe-LDH, the rate constant of TMP degradation of CuFe-LDH/GO was doubled. The results also indicated that acidic and alkaline conditions were not favorable for TMP degradation, and the catalytic activity of the used photocatalyst has not decreased significantly after 720 h of continuous recycling. Overall, CuFe-LDH/GO could be a promising photocatalyst for the treatment of wastewater containing antibiotics.